Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Quality of Care
Researchers from University Hospital discuss findings in cancer vaccines quality of care
January 13th, 2009
New investigation results, 'Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine,' are detailed in a study published in Oncology Reports. "Patients with disseminated colorectal cancer have a poor prognosis. Preliminary studies have shown encouraging results from vaccines based on dendritic cells," investigators in Gentofte, Denmark report. "The aim of this phase II study was to evaluate the effect of treating patients with advanced colorectal cancer with a cancer vaccine based on dendritic cells pulsed with an allogenic tumor cell lysate. Twenty patients with advanced colorectal cancer were consecutively enrolled....
Source: Cancer Weekly (2009-01-13)
|
